Jeffrey C. Fink

13.2k total citations · 1 hit paper
175 papers, 8.3k citations indexed

About

Jeffrey C. Fink is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Transplantation. According to data from OpenAlex, Jeffrey C. Fink has authored 175 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Nephrology, 28 papers in Cardiology and Cardiovascular Medicine and 28 papers in Transplantation. Recurrent topics in Jeffrey C. Fink's work include Dialysis and Renal Disease Management (33 papers), Renal Transplantation Outcomes and Treatments (26 papers) and Chronic Kidney Disease and Diabetes (26 papers). Jeffrey C. Fink is often cited by papers focused on Dialysis and Renal Disease Management (33 papers), Renal Transplantation Outcomes and Treatments (26 papers) and Chronic Kidney Disease and Diabetes (26 papers). Jeffrey C. Fink collaborates with scholars based in United States, United Kingdom and Italy. Jeffrey C. Fink's co-authors include Matthew R. Weir, Stephen T. Bartlett, Charles B. Cangro, Min Zhan, Stephen L. Seliger, Van Doren Hsu, David K. Klassen, John C. Papadimitriou, Cinthia B. Drachenberg and Steven A. Blahut and has published in prestigious journals such as JAMA, Blood and Journal of the American College of Cardiology.

In The Last Decade

Jeffrey C. Fink

172 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease

2009 465 citations Lisa M. Einhorn, Min Zhan et al. Archives of Internal Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey C. Fink United States	48	2.1k	1.6k	1.5k	1.3k	1.2k	175	8.3k
David T. Gilbertson United States	48	4.4k 2.1×	1.9k 1.2×	1.5k 1.0×	1.7k 1.3×	1.4k 1.2×	180	10.2k
Kevin C. Abbott United States	57	2.8k 1.3×	2.4k 1.5×	1.7k 1.1×	2.6k 1.9×	996 0.8×	216	9.4k
Wisit Cheungpasitporn United States	45	2.3k 1.1×	2.0k 1.2×	1.7k 1.1×	606 0.5×	1.7k 1.4×	538	9.4k
Julio Pascual Spain	52	2.6k 1.2×	2.8k 1.7×	1.1k 0.7×	3.6k 2.7×	709 0.6×	319	9.3k
Carmel M. Hawley Australia	53	6.1k 2.9×	2.4k 1.5×	1.8k 1.2×	1.3k 0.9×	1.3k 1.1×	426	11.0k
Natasha Wiebe Canada	53	3.8k 1.8×	2.1k 1.3×	2.0k 1.3×	826 0.6×	1.9k 1.6×	146	11.5k
Bart Maes Belgium	53	2.2k 1.1×	2.7k 1.7×	1.1k 0.8×	2.1k 1.5×	336 0.3×	215	8.9k
Charat Thongprayoon United States	45	2.0k 0.9×	1.6k 1.0×	2.0k 1.3×	403 0.3×	1.3k 1.1×	486	8.9k
Steven J. Chadban Australia	62	4.5k 2.1×	2.7k 1.7×	1.6k 1.1×	3.6k 2.7×	1.0k 0.9×	283	12.8k
Wolfgang C. Winkelmayer United States	59	4.5k 2.1×	1.9k 1.2×	1.7k 1.1×	1.3k 1.0×	3.0k 2.5×	364	12.5k

Countries citing papers authored by Jeffrey C. Fink

Since Specialization

Citations

This map shows the geographic impact of Jeffrey C. Fink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey C. Fink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey C. Fink more than expected).

Fields of papers citing papers by Jeffrey C. Fink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey C. Fink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey C. Fink. The network helps show where Jeffrey C. Fink may publish in the future.

Co-authorship network of co-authors of Jeffrey C. Fink

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey C. Fink. A scholar is included among the top collaborators of Jeffrey C. Fink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey C. Fink. Jeffrey C. Fink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fink, Jeffrey C., T. S. Moise, R. Baumann, et al.. (2024). Reliability Assessment of a-IGZO and ZnO Thin Film Transistors (TFTs) to X-ray irradiation. 1–6. 1 indexed citations

Zheng, Zihe, Sushrut S. Waikar, Insa M. Schmidt, et al.. (2021). Subtyping CKD Patients by Consensus Clustering: The Chronic Renal Insufficiency Cohort (CRIC) Study. Journal of the American Society of Nephrology. 32(3). 639–653. 42 indexed citations

Lunyera, Joseph, et al.. (2020). A Patient Safety Educational Tool for Patients With Chronic Kidney Disease: Development and Usability Study. JMIR Formative Research. 4(5). e16137–e16137. 6 indexed citations

Schrauben, Sarah J., Hsiang‐Yu Chen, Eugene Lin, et al.. (2020). Hospitalizations among adults with chronic kidney disease in the United States: A cohort study. PLoS Medicine. 17(12). e1003470–e1003470. 47 indexed citations

Schrauben, Sarah J., Lawrence J. Appel, Eleanor Rivera, et al.. (2020). Mobile Health (mHealth) Technology: Assessment of Availability, Acceptability, and Use in CKD. American Journal of Kidney Diseases. 77(6). 941–950.e1. 59 indexed citations

Rajagopalan, Sanjay, Mohamad Amer Alaiti, Aditya Goud, et al.. (2017). Design of the Magnetic Resonance Imaging Evaluation of Mineralocorticoid Receptor Antagonism in Diabetic Atherosclerosis (MAGMA) Trial. Clinical Cardiology. 40(9). 633–640. 8 indexed citations

Snitker, Søren, Elsayed Z. Soliman, Rajat Deo, et al.. (2017). Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations. Clinical Journal of the American Society of Nephrology. 12(9). 1409–1417. 14 indexed citations

Zhan, Min, et al.. (2015). Chronic Pain and Analgesic Use in CKD. Clinical Journal of the American Society of Nephrology. 10(3). 435–442. 35 indexed citations

Grunwald, Juan E., Maureen G. Maguire, Maxwell Pistilli, et al.. (2012). Association Between Retinopathy and Cardiovascular Disease in Patients With Chronic Kidney Disease (from the Chronic Renal Insufficiency Cohort [CRIC] Study). The American Journal of Cardiology. 110(2). 246–253. 41 indexed citations

10.

Ellingson, Katherine, Rakhee Palekar, Cynthia Lucero, et al.. (2012). Vascular access hemorrhages contribute to deaths among hemodialysis patients. Kidney International. 82(6). 686–692. 47 indexed citations

11.

Einhorn, Lisa M., Min Zhan, Van Doren Hsu, et al.. (2009). The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease. Archives of Internal Medicine. 169(12). 1156–1156. 465 indexed citations breakdown →

12.

Semba, Richard D., Jeffrey C. Fink, Kai Sun, et al.. (2008). Carboxymethyl-lysine, an advanced glycation end product, and decline of renal function in older community-dwelling adults. European Journal of Nutrition. 48(1). 38–44. 36 indexed citations

13.

Semba, Richard D., Luigi Ferrucci, Jeffrey C. Fink, et al.. (2008). Advanced Glycation End Products and Their Circulating Receptors and Level of Kidney Function in Older Community-Dwelling Women. American Journal of Kidney Diseases. 53(1). 51–58. 53 indexed citations

14.

Jones-Burton, Charlotte, et al.. (2005). Survival Benefit of Recombinant Human Erythropoietin Administration prior to Onset of End-Stage Renal Disease: Variations across Surrogates for Quality of Care and Time. Nephron Clinical Practice. 101(2). c79–c86. 20 indexed citations

15.

Provenzano, Robert, et al.. (2004). Once-weekly epoetin alfa for treating the anemia of chronic kidney disease. Clinical Nephrology. 61(6). 392–405. 56 indexed citations

16.

Ramos, Emilio, Cinthia B. Drachenberg, Ravinder K. Wali, et al.. (2002). BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program.. PubMed. 143–53. 141 indexed citations

17.

Stern, Jean M., Keith M. Sullivan, Susan M. Ott, et al.. (2001). Bone density loss after allogeneic hematopoietic stem cell transplantation: A prospective study. Biology of Blood and Marrow Transplantation. 7(5). 257–264. 81 indexed citations

18.

Stehman‐Breen, Catherine, Leslie Miller, Jeffrey C. Fink, & Stephen M. Schwartz. (2000). Pre‐eclampsia and premature labour among pregnant women with haematuria. Paediatric and Perinatal Epidemiology. 14(2). 136–140. 7 indexed citations

19.

Drachenberg, Cinthia B., Charles B. Cangro, Patricia M. Bourquin, et al.. (1999). Human polyoma virus in renal allograft biopsies: Morphological findings and correlation with urine cytology. Human Pathology. 30(8). 970–977. 193 indexed citations

20.

Fink, Jeffrey C., et al.. (1953). Stilbamidine ' in the treatment of cutaneous blastomycosis. Report of a case.. JAMA. 151(16). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact